13D Filing: TPG Group Holdings (SBS) Advisors, Inc. and Quintiles IMS Holdings Inc (Q)

Page 11 of 11

Page 11 of 11 – SEC Filing

INDEX TO EXHIBITS

  1. Agreement of Joint Filing by TPG Group Holdings (SBS) Advisors, Inc., TPG Advisors
    VI, Inc., TPG Advisors V, Inc., TPG Biotech Advisors, Inc., David Bonderman and James G. Coulter, dated as of October 13, 2016
    (incorporated by reference to Exhibit 1 to Schedule 13D filed with the Commission on October 13, 2016 by TPG Group Holdings (SBS)
    Advisors, Inc., TPG Advisors VI, Inc., TPG Advisors V, Inc., TPG Biotech Advisors, Inc., David Bonderman and James G. Coulter).
  2. Agreement and Plan of Merger, dated as of May 3, 2016, by and among the IMS Health
    Holdings, Inc. and Quintiles Transnational Holdings Inc. (incorporated herein by reference to Exhibit 2.1 to the Issuer’s
    Current Report on Form 8-K filed with the Commission on May 3, 2016).
  3. Shareholders Agreement, dated as of May 3, 2016, by and among Quintiles Transnational
    Holdings Inc. and Certain Shareholders (incorporated herein by reference to Exhibit 10.4 to the Issuer’s Current Report on
    Form 8-K filed with the Commission on May 3, 2016).
  4. Share Repurchase Agreement, dates as of February 23, 2017, by and among Quintiles
    IMS Holdings, Inc. and the selling shareholders set forth in Schedule I thereto (incorporated herein by reference to Exhibit 10.1
    to the Issuer’s Current Report on Form 8-K filed with the Commission on February 24, 2017).
  5. Underwriting Agreement, dated May 24, 2017 by and among Quintiles IMS Holdings, Inc.,
    the selling stockholders listed in Schedule I thereto and Morgan Stanley & Co. LLC (incorporated by reference to Exhibit 1.1
    to the Issuer’s Current Report on Form 8-K filed with the Commission on May 31, 2017).
  6. Form of Lock-Up Letter, dated May 24, 2017, by and among each of the selling stockholders
    listed in Schedule I to the Underwriting Agreement and Morgan Stanley & Co. LLC (incorporated by reference to Exhibit A to
    Exhibit 1.1 to the Issuer’s Current Report on Form 8-K filed with the Commission on May 31, 2017).
11

Follow Iqvia Holdings Inc.

Page 11 of 11